Conflict of Interest: M.H. has received fee from Photocure/Galderma for speaking and is on the advisory board for Galderma International regarding photodynamic therapy of organ transplant recipients. None of the other listed authors have any conflict of interest regarding this publication.
Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment†
Article first published online: 26 SEP 2011
Copyright © 2011 Wiley-Liss, Inc.
Lasers in Surgery and Medicine
Volume 43, Issue 8, pages 804–813, September 2011
How to Cite
Hædersdal, M., Katsnelson, J., Sakamoto, F.H., Farinelli, W.A., Doukas, A.G., Tam, J. and Anderson, R.R. (2011), Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg. Med., 43: 804–813. doi: 10.1002/lsm.21096
- Issue published online: 26 SEP 2011
- Article first published online: 26 SEP 2011
- Manuscript Accepted: 24 JUN 2011
- Danish Council for Independent Research/Medical Sciences (FSS)
- Aage Bang Foundation
- A.P Møller Foundation for the Advancement of Medical Science
- drug delivery;
- fractional laser ablation;
- methyl 5-aminolevulinic acid;
- photodynamic therapy;
Background and Objectives
Photodynamic therapy (PDT) of thick skin lesions is limited by topical drug uptake. Ablative fractional resurfacing (AFR) creates vertical channels that may facilitate topical PDT drug penetration and improve PDT-response in deep skin layers. The purpose of this study was to evaluate whether pre-treating the skin with AFR before topically applied methyl aminolevulinate (MAL) could enable a deep PDT-response.
Materials and Methods
Yorkshire swine were treated under general anesthesia with a fractional CO2 laser using stacked single pulses of 3 milliseconds, 91.6 mJ per pulse and subsequent topical MAL application for 3 hours (Metvix®). Red light (LED arrays) was then delivered at fluences of 37 and 200 J/cm2. Fluorescent photography and microscopy was used to quantify MAL-induced porphyrin distribution and PDT-induced photobleaching at the skin surface and five specific depths down to 1,800 µm.
Laser-ablated channels were approximately 1,850 µm deep, which significantly increased topical MAL-induced porphyrin fluorescence (hair follicles, dermis, P < 0.0001) and PDT response, both superficially and deep, versus topical MAL application alone. The fraction of porphyrin fluorescence lost by photobleaching was slightly less after 37 J/cm2 than after 200 J/cm2 (overall median values 67–90%; 37 vs. 200 J/cm2, P > 0.05 for all but one comparison). Photobleaching was steady throughout skin layers and did not vary significantly with skin depth at either LED fluence (P > 0.05).
AFR greatly facilitates topical MAL-induced porphyrins and the fraction of photobleached porphyrins is similar for superficial and deep skin. These observations are consistent with AFR-enhanced uptake of MAL, increased porphyrin synthesis, and photodynamic activation of deep porphyrins even at the lower fluence of 37 J/cm2, widely used in clinical practice. AFR appears to be a clinically practical means for improving PDT deep into the skin. Clinical studies are suggested to evaluate selectivity in targeting dysplastic cell types. Lasers Surg. Med. © 2011 Wiley-Liss, Inc.